石油精製 (各産業界の省エネルギ-展望 )
Published in 省エネルギー • Jan 1, 1993
Authors:
貴和 古沢
Abstract
The clinical use of the alkylating oxazaphosphorine ifosfamide is hampered by a potentially severe encephalopathy. S-carboxymethylcysteine (SCMC), a metabolite of ifosfamide (IF), activates the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptor, causes neuronal acidific...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!